An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis...

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Streptococcus pneumoniae poses a significant threat, necessitating new therapeutic strategies.
• Targeting essential bacterial enzymes like MurF is crucial for developing effective antibiotics.
• Novel screening methods are vital for identifying potent and selective drug candidates.

Purpose of the Study:

• To discover a new class of inhibitors for the Streptococcus pneumoniae cell wall biosynthesis enzyme, MurF.
• To develop and validate a novel affinity screening strategy for identifying selective enzyme inhibitors.
• To demonstrate the applicability of this strategy for various protein targets and ligand libraries.

Main Methods:

• Employed a novel affinity screening approach utilizing equilibrium binding.
• Integrated iterative ultrafiltration steps for compound enrichment.
• Utilized mass spectrometry for ligand identification.
• Implemented electronic subtraction to remove non-selective compounds and identify MurF-specific ligands.

Main Results:

• Successfully identified a new class of specific inhibitors for the MurF enzyme.
• Demonstrated the effectiveness of the novel screening strategy in distinguishing selective ligands from promiscuous compounds.
• Validated the method's ability to bypass traditional selectivity panels.

Conclusions:

• The developed affinity screening strategy is highly effective for discovering specific enzyme inhibitors.
• This method offers a robust platform for identifying novel drug candidates against essential bacterial targets.
• The approach is broadly applicable to diverse soluble protein targets and ligand libraries, advancing drug discovery efforts.